PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract

PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract

Order Increases the Value of Existing Department of Defense Contract; PositiveID Increases Revenue/Backlog Estimate to $3.5 Million; Reiterates Revenue Guidance of $4-10 Million Through the End of 2015


PositiveID Corporation (“PositiveID” or “Company”) (PSID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID’s M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).

“M-BAND continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins.”

“We view this latest purchase order as another validation of not only our technical capabilities, but also our ability to collaborate with large commercial and government partners, while continuing to execute our strategy,” stated William J. Caragol, Chairman and CEO of PositiveID. “We are very pleased to continue the testing of our M-BAND units to protect our nation’s warfighters and defenders.”

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.

“PositiveID’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results from a sample in less than 20 minutes”

About Firefly

Diagnostics at the point of need, compared to two to four hours for a lab device, using real-time TaqMan(R) PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need for more rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives.

About M-BAND

The technology was developed under contract with the U.S. Department of Homeland Security (“DHS”) Science & Technology directorate, which included $30 million of contract funding, to detect an attack with a biological weapon.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s